SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-15-324422
Filing Date
2015-09-21
Accepted
2015-09-21 16:14:11
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d20449d424b5.htm 424B5 559263
2 GRAPHIC g20449g61l04.jpg GRAPHIC 167728
3 GRAPHIC g20449g88b19.jpg GRAPHIC 18996
  Complete submission text file 0001193125-15-324422.txt   817789
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-204509 | Film No.: 151117533
SIC: 2834 Pharmaceutical Preparations